BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21484622)

  • 21. Hyperglycemia in critically ill patients.
    Knieriem M; Otto CM; Macintire D
    Compend Contin Educ Vet; 2007 Jun; 29(6):360-2, 364-72; quiz 372. PubMed ID: 17724990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lowering of glucose in critical care: a randomized pilot trial.
    McMullin J; Brozek J; McDonald E; Clarke F; Jaeschke R; Heels-Ansdell D; Leppert R; Foss A; Cook D
    J Crit Care; 2007 Jun; 22(2):112-8; discussion 118-9. PubMed ID: 17548021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Diagnostic aspects and analytical problems of glycemia monitoring in intensive care unit patients].
    Solnica B
    Przegl Lek; 2006; 63(9):792-6. PubMed ID: 17479872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intensive insulin therapy in critically ill patients--pro].
    Ellger B
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2480. PubMed ID: 17066359
    [No Abstract]   [Full Text] [Related]  

  • 25. Endocrine and metabolic disturbances in critical illness: relation to mechanisms of organ dysfunction and adverse outcome.
    Langouche L; Mesotten D; Vanhorebeek I
    Verh K Acad Geneeskd Belg; 2010; 72(3-4):149-63. PubMed ID: 21067067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of an insulin infusion nomogram for intensive glucose control in critically ill patients.
    Chant C; Wilson G; Friedrich JO
    Pharmacotherapy; 2005 Mar; 25(3):352-9. PubMed ID: 15843282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Insulin infusion for critically ill patients].
    Skeie S; Søreide E; Cooper J
    Tidsskr Nor Laegeforen; 2007 Sep; 127(18):2378-81. PubMed ID: 17895943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Artificial nutrition in the patient with hyperglycemia].
    Fatati G; Coaccioli S
    Clin Ter; 2006; 157(1):5-7. PubMed ID: 16669545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood glucose concentration and outcome of critical illness: the impact of diabetes.
    Egi M; Bellomo R; Stachowski E; French CJ; Hart GK; Hegarty C; Bailey M
    Crit Care Med; 2008 Aug; 36(8):2249-55. PubMed ID: 18664780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood glucose control in the intensive care unit: benefits and risks.
    Gunst J; Van den Berghe G
    Semin Dial; 2010; 23(2):157-62. PubMed ID: 20525106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive insulin therapy for acute hyperglycemia.
    Read JL; Cheng EY
    AACN Adv Crit Care; 2007; 18(2):200-12. PubMed ID: 17473549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonobese, insulin-deficient Ins2Akita mice develop type 2 diabetes phenotypes including insulin resistance and cardiac remodeling.
    Hong EG; Jung DY; Ko HJ; Zhang Z; Ma Z; Jun JY; Kim JH; Sumner AD; Vary TC; Gardner TW; Bronson SK; Kim JK
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1687-96. PubMed ID: 17911348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing intravenous glucose load in the presence of normoglycemia: effect on outcome and metabolism in critically ill rabbits.
    Derde S; Vanhorebeek I; Ververs EJ; Vanhees I; Darras VM; Van Herck E; Larsson L; Van den Berghe G
    Crit Care Med; 2010 Feb; 38(2):602-11. PubMed ID: 19851097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative contribution of glycogenolysis and gluconeogenesis to hepatic glucose production in control and diabetic rats. A re-examination in the presence of euglycaemia.
    Giaccari A; Morviducci L; Pastore L; Zorretta D; Sbraccia P; Maroccia E; Buongiorno A; Tamburrano G
    Diabetologia; 1998 Mar; 41(3):307-14. PubMed ID: 9541171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E; Minuto F; Colao A; Ferone D
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glycemic control in critically ill patients before and after institution of an intensive insulin infusion protocol: circadian rhythm and the quality duration calculator.
    Keene A; Hailpern S; Anees S; Sandhu J; Harris M; Ashton L; Bellin E
    J Intensive Care Med; 2010; 25(1):31-8. PubMed ID: 20034953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Benefits and methods of achieving strict glycemic control in the ICU.
    Roberts SR; Hamedani B
    Crit Care Nurs Clin North Am; 2004 Dec; 16(4):537-45. PubMed ID: 15571942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pathophysiology of impaired insulin sensitivity in the perioperative period].
    Assmann A; Spranger J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2011 Apr; 46(4):250-5; quiz 256. PubMed ID: 21484620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insulin resistance and its impact on the approach to therapy of type 2 diabetes.
    Laakso M
    Int J Clin Pract Suppl; 2001 Sep; (121):8-12. PubMed ID: 11594246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intensive insulin therapy in critically ill patients--contra].
    Marx G; Brunkhorst FM; Reinhart K
    Dtsch Med Wochenschr; 2006 Nov; 131(44):2481. PubMed ID: 17066360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.